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Summary
Previous mode of action studies identified methionine
aminopeptidase 2 (MetAP-2) as the target of the anti-
angiogenic natural product fumagillin and its drug
candidate analog, TNP-470. We report here that TNP-
470-mediated MetAP-2 inhibition blocks noncanonical
Wnt signaling, which plays a critical role in develop-
ment, cell differentiation, and tumorigenesis. Consis-
tent with this finding, antisense MetAP-2 morpholino
oligonucleotide injection in zebrafish embryos pheno-
copies gastrulation defects seen in noncanonical
Wnt5 loss-of-function zebrafish mutants. MetAP-2 in-
hibition or depletion blocks signaling downstream of
the Wnt receptor Frizzled, but upstream of Calmodu-
lin-dependent Kinase II, RhoA, and c-Jun N-terminal
Kinase. Moreover, we demonstrate that TNP-470 does
not block the canonical Wnt/b-catenin pathway. Thus,
TNP-470 selectively regulates noncanonical over ca-
nonical Wnt signaling and provides a unique means
to explore anddissect thebiological systemsmediated
by these pathways.
Introduction
Targeting the tumor vasculature by using antiangiogenic
therapeutics has been an attractive strategy to limit the
size and metastases of tumors. One of the most potent
small-molecule antiangiogenic agents is the natural
product fumagillin (1), which was isolated in the Folkman
lab from a contaminating Aspergillus fumagatus colony
in an endothelial cell culture. Fumagillin was subse-
quently chemically modified to create the drug candi-
date TNP-470 (2) [1], which was tested in Phase I/II trials
for Kaposi’s sarcoma, renal cell carcinoma, brain can-
cer, breast cancer, cervical cancer, and prostate cancer
[2]. Using a chemical genetics approach, we previously
identified methionine aminopeptidase 2 (MetAP-2) as a
direct binding protein of fumagillin [3], and we published
the structure of human MetAP-2 bound to fumagillin [4].
Both fumagillin and TNP-470 specifically bind MetAP-2
*Correspondence: craig.crews@yale.eduand inhibit its activity [3, 5]. However, a role for MetAP-
2 in an intracellular signaling pathway has not been iden-
tified. Here, we continue our mode of action studies of
TNP-470 by combining model organism (zebrafish)
small-molecule chemical genetics with nucleic acid-
based genetic techniques (MO and siRNA) to identify
TNP-470 as a selective inhibitor of noncanonical Wnt
signaling.
How cells coordinate polarity and movement within a
larger population is a fundamental question in develop-
mental biology. Genetic studies of the Drosophila wing
epithelia have identified several genes that function to
establish asymmetric cell polarities by coordinating
the organization of the cytoskeleton [6]. These genes
comprise the planar cell polarity pathway (PCP), which
includes some genes known to be components (i.e.,
Frizzled, Dishevelled) of the canonical Wnt signaling
pathway that leads to b-catenin-mediated transcription
(Figure 1). Additional core PCP proteins constituting a
‘‘noncanonical’’ Wnt signaling pathway include Daam1,
RhoA, c-Jun N-terminal Kinase (JNK), and CaMKII. In
addition to Drosophila wing epithelia polarization, non-
canonical Wnt signaling has been implicated in the com-
plex coordination of cell polarity, adhesion, and move-
ment required for vertebrate gastrulation. A key set
of morphogenetic movements during gastrulation is
the mediolateral narrowing and anterior-posterior tissue
lengthening necessary to form the embryonic axis [7].
Studies have demonstrated that these ‘‘convergence
and extension’’ (CE) movements are regulated by non-
canonical signaling [8, 9]. For example, Wnt5 has been
implicated in the morphogenetic movements during
Xenopus and zebrafish gastrulation [10–12]. Unlike ca-
nonical Wnt signaling, which is fairly well characterized,
noncanonical Wnt signaling pathways are not fully eluci-
dated. For example, it remains to be determined if mul-
tiple noncanonical pathways exist since various subsets
of genes reported to be involved in noncanonical Wnt
signaling have been linked to biological systems as di-
verse as neurogenesis [13], cell adhesion [14], and cell
polarization [15, 16]. Alternatively, a ‘‘core’’ noncanoni-
cal Wnt pathway may exist, and these observed differ-
ences may simply reflect the differences inherent in
the various systems studied. Unlike canonical Wnt sig-
naling, for which both small-molecule agonists and
antagonists have been reported [17, 18], the study of
noncanonical Wnt signaling has been hampered by the
lack of specific small-molecule probes of this pathway.
To follow up on our recent finding that MetAP-2
knockout murine embryos fail to undergo gastrulation
[19], here we explore the role of MetAP-2 in early zebra-
fish development. We show that MetAP-2 is necessary
for noncanonical Wnt signaling in vivo and in cell culture
systems. Moreover, we report that the MetAP-2 inhibitor
TNP-470 selectively and potently inhibits noncanonical
Wnt signaling downstream or at the level of Frizzled re-
ceptors and upstream of JNK and CaMKII activation.
These studies demonstrate the first small-molecule in-
hibitor for the investigation of the diverse biological sys-
tems mediated by these important signaling pathways.
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canonical Wnt Signaling
Although not all Wnt signaling effectors/
transducers are included, key components
relevant to this work are depicted.Results
MetAP-2 Genetically Interacts with Wnt5
in Zebrafish
Using the zebrafish (Danio rerio) developmental process
as a chemical genetic model to elucidate the mode of
action of the small-molecule compound TNP-470, we
treated zebrafish embryos with the MetAP-2 inhibitor
fumagillin (1) and TNP-470 (2) (Figure 2). While these ex-
periments resulted in a truncated tail phenotype (data
not shown), the penetrance was low, possibly due to
poor permeability across the chorionic membrane. We
identified and cloned zebrafish MetAP-2 (chromosome
25), and it has ubiquitous expression in early develop-
ment. Interestingly, at the time of vascularization, this
MetAP-2 transcript is enriched in the intersomitic re-
gions (Figure S1; see the Supplemental Data available
with this article online). Thus, we next knocked down
MetAP-2 expression in zebrafish embryos by antisense
morpholino oligonucleotides (MO) injection. The result-
ing zebrafish embryos displayed a highly penetrate trun-
cated posterior phenotype similar to the AP axis tail
extension defect observed in Wnt5 MO-injected zebra-
fish, although both of these low-dose MOs show milder
gastrulation defects than the Wnt5 mutant pipetail (ppt)
(Figures 3A–3D). This tail phenotype was also observed
by using a second MO targeting a different splice site
not observed in 5 base pair mismatch MetAP-2 MO-in-
jected embryos (data not shown). Downregulation of
MetAP-2 protein was confirmed by immunoblot analysis
(Figure S2). Interestingly, embryos coinjected with a
combination of low-dose MetAP-2 and Wnt5 MOs re-
sulted in a strong synergistic effect rather than an addi-
tive effect, suggesting a genetic interaction between
these two molecules (Figure 3E; Table 1). Furthermore,
these MetAP-2 MO-injected zebrafish displayed broader
MyoD somite staining consistent with the observed
MyoD staining in ppt fish [20] (Figure S3). This gastrula-
tion defect is similar to but not as severe as the complete
loss of gastrulation in the murine MetAP-2 knockout
mouse [19]. This discrepancy between the two model
systems may be due to (1) an incomplete antisenseMO MetAP-2 knockdown in the zebrafish system, (2)
the significant contribution of presynthesized maternal
MetAP-2 protein in the fish egg, which could partially
rescue loss of embryonic MetAP-2 mRNA, or (3) genetic
redundancy as a result of the teleost genomic duplica-
tion (we recently identified a related MetAP-2 gene on
chromosome 4).
To evaluate if MetAP-2 has a general role in nonca-
nonical signaling or is only specific for Wnt5 signaling,
zebrafish embryos were coinjected with MOs targeting
MetAP-2 and the noncanonical Wnt11. Injection of the
Wnt11 MO alone resulted in 12% of the embryos dis-
playing a moderate or severe eye defect consistent
with the phenotype of the Wnt11 mutant silberblick
(slb). However, coinjection with MetAP-2 MO more
than tripled (38%) the observed moderate/severe eye
phenotype (Table S1).
It has been shown that Wnt5a activates noncanonical
Wnt signaling through intracellular Ca2+ release [21] and
the activation of Ca2+-sensing enzymes such as CamKII.
In addition, it has been demonstrated that injection of
truncated, constitutively activated CamKII (CamKIItr)
mRNA is sufficient to rescue the Wnt5 homozygous mu-
tant tail defect [22]. Thus, we wanted to determine if ex-
ogenous CamKII activity was also able to suppress the
MetAP-2 MO-induced phenotypes. As demonstrated
in a genetic rescue experiment (Figure 3F; Table 1),
Figure 2. Structure of the Antiangiogenic Natural Product Fumagil-
lin, 1, the Clinical Trial Drug Candidate, 2, and the Nonspecific
MetAP-1/MetAP-2 Inhibitory Natural Product Bengamide E, 3
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MetAP-2 and Wnt5 in Zebrafish
(A) Wild-type zebrafish at 24 hr postfertiliza-
tion denoting normal anterior-posterior
length.
(B) Homozygous ppt embryo.
(C) Coinjection of Wnt5 MO and a missense
MetAP-2 MO as control.
(D) MetAP-2 MO injection phenocopies Wnt5
MO-injected zebrafish, as shown in (C).
(E) Coinjection of MetAP-2 and Wnt5 MOs in
zebrafish embryos at minimal concentrations
resulted in a strong synergistic effect rather
than an additive effect (also see Table 1).
(F) Coinjection of activated CamKIItr RNA with
MetAP-2 MO partially rescues the MetAP-2
MO phenotype (also see Table 1).coinjection of CamKIItr mRNA withMetAP-2MO partially
suppressed the MO-induced phenotype (from a 37%
frequency of shortened AP axis in MetAP-2 MO only to
a 17% frequency in MetAP-2 MO plus CamKIItr). Thus,
these genetic experiments clearly demonstrate a re-
quirement for MetAP-2 in noncanonical Wnt5 signaling.
MetAP-2 Is Required for Noncanonical,
but Not Canonical, Wnt Signaling
Since the mouse teratocarcinoma F9 system played an
important role in elucidating the noncanonical Wnt5a/
Rfz2 pathway in mammalian cells and faithfully recapit-
ulates what is observed in zebrafish [23, 24], we chose
to utilize this system to confirm the genetic interaction
between MetAP-2 and Wnt5a observed in zebrafish em-
bryos. In this assay, the activation of either canonical or
noncanonical Wnt receptors (e.g., Fz1 and Fz2, respec-
tively) leads to differentiation into primitive endoderm
(PE), as measured by the induction of several markers
such as tissue plasminogen activator (tPA) and the cyto-
keratin Endo-A [23, 24]. We therefore tested the ability ofTNP-470 (2) to disrupt Wnt5a-mediated induction of PE
in the F9 cell system. As shown in Figure 4A, 10 nM TNP-
470 was sufficient to inhibit PE induction, as assessed
by tPA activity levels in F9 cells expressing the nonca-
nonical Wnt receptor Fz2 when cocultured with Wnt5a-
expressing HEK293 cells. In contrast, PE induction by
retinoic acid was unaffected. This inhibition was not
due to the cytostatic activity of TNP-470 observed in en-
dothelial cells since 10 nM TNP-470 had a negligible
effect on F9 cell proliferation (Figure S4). In addition,
we found that directly knocking down 90% of MetAP-2
expression with MetAP-2 gene (MAP2)-specific siRNA
resulted in a dramatic decrease in PE induction to levels
similar to those seen in TNP-470-treated cells (Fig-
ure 4B). In parallel experiments in which cytokeratin
Endo-A antibody (TROMA-1) staining was used to mon-
itor PE induction, TNP-470 potently inhibited Wnt5a/Fz2
signaling (Figure 4C). Similarly, siRNA-mediated MetAP-
2 downregulation also blocked Wnt5a-induced cytoker-
atin Endo-A induction (Figure 3C). These data indicate
that MetAP-2 activity is required for Wnt5a function.Table 1. Wnt5 and MetAP-2 Interact Genetically
% Wild-Type
% Moderately
Morphant
% Highly
Morphant
% Severely
Truncated n
150 mM Wnt5 and 300 mM MetAP-2 MO 1.8 54.1 31.2 12.9 109
150 mM Wnt5 MO 89.3 8.0 2.7 0 75
300 mM MetAP-2 MO 80.6 12.2 6.1 1.1 98
600 mM MetAP-2 MO plus control 27 35 37 0 137
600 mM MetAP-2 MO plus CamKIItr 53 30 17 0 182
Wnt5 (150 mM) and MetAP-2 (300 mM) antisense morpholinos act synergistically to elicit tail extension defects, and activated CamKIItr partially
rescues the MetAP-2 MO phenotype. (‘‘Moderately Morphant’’ describes a weaker ppt mutant phenotype, ‘‘Highly Morphant’’ embryos have
a strong ppt phenotype, and ‘‘Severely Truncated’’ describes embryos that fail to extend past the yolk.)
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tion Was Attenuated by TNP-470 or siRNA-
Mediated MetAP-2 Downregulation
(A) F9 cells expressing wild-type rat Frizzled
2 (Rfz2) were cocultured with HEK293 cells
expressing Wnt5a in the presence or absence
of 10 nM TNP-470 for 4 days. The primitive
endoderm (PE) marker tPA was measured
by ELISA. Retinoic acid-induced F9 cell differ-
entiation was unaffected by TNP-470 (insert).
Means + SD are shown (n = 6).
(B) F9 cells with siRNA-mediated MAP2
knockdown showed a similar inhibitory effect
as TNP-470. Means + SD are shown (n = 6).
(C) Wnt5a-induced F9 cell differentiation was
monitored by immunofluorescence staining
with TROMA-1 antibody against PE-specific
cytokeratin Endo-A. Identical fields are
depicted showing phase contrast (left),
HEK293 cells coexpressing GFP with Wnt5a
(center), and TROMA induction in Rfz2-ex-
pressing F9 cells (right).While generally believed to be a noncanonical Wnt
family member [25], Wnt5a has also been reported to in-
duce axis duplication inXenopus embryos when overex-
pressed with the canonical Frizzled Fz5 [26]. Since both
canonical and noncanonical Wnt signaling can induce
PE formation in the F9 cell system [23, 24], we investi-
gated whether both pathways require MetAP-2. To avoid
any ambiguity regarding crosstalk between Wnt5a and
different Frizzled receptors, we used isoproterenol-re-
sponsive chimeric Frizzled receptors, which have proven
useful in the study of signaling events downstream of
canonical and noncanonical Frizzled proteins [27, 28].
These chimeric receptors consist of the extracellular
and transmembrane domains of b2-adrenergic receptor
(b2-AR) and the putative intracellular loops of the rat
Frizzled-1/Rfz1 (canonical) or Frizzled-2/Rfz2 (nonca-
nonical) receptors. Activation with the b2-AR agonist
isoproterenol of either chimeric receptor individually ex-
pressed in F9 cells leads to PE induction (Figure 5A).
Confirming the observed TNP-470 inhibition of Wnt5a-
induced PE induction (Figures 4A and 4C), we observed
that isoproterenol-induced PE formation through b2-AR/
Rfz2 in F9 cells was attenuated by TNP-470, as assayed
by TROMA-1 staining. Similarly, knockdown of endoge-
nous MetAP-2 by siRNA blocked isoproterenol-trig-
gered PE formation in F9 cells expressing b2-AR/Rfz2
(Figure 5A). In contrast, PE induction through b2-AR/
Rfz1 was not affected by TNP-470 or by siRNA targeting
MAP2 (Figure 5A). Thus, our results strongly suggest that
MetAP-2 is required for signaling through the noncanon-ical Wnt receptor Frizzled 2, but not the canonical Wnt
receptor Frizzled 1.
It is well established that activation of the canonical
Wnt pathway leads to b-catenin stabilization and nuclear
translocation, which subsequently activates lymphoid-
enhancer factor (LEF)/T cell factor (TCF)-regulated tran-
scription [29, 30]. To confirm that MetAP-2 function is
not involved in the canonical Wnt pathway, we tested
whether fumagillin (1), the potent parent compound of
TNP-470, regulates LEF/TCF transactivation by using
the LEF/b-catenin-responsive TOPflash-luciferase re-
porter [31]. As shown in Figure 5C, 100 mM isoproterenol
induced a 6-fold increase in TCF-luciferase after 6 hr in
b2-AR/Rfz1 cells. Preincubation with 10 nM fumagillin
had no effect on TCF transactivation. Thus, once again,
our results indicate that MetAP-2 activity does not affect
the Wnt/b-catenin pathway.
MetAP-2 Acts Upstream of CamKII, RhoA,
and JNK Activation
To study further whether MetAP-2 is required for the
induction of intracellular calcium, as suggested by our
zebrafish experiments, we investigated the effect of
MetAP-2 inhibition on CamKII in F9 cells. Treatment of
b2-AR/Rfz2-expressing F9 cells with 100 mM isoprotere-
nol for 10 min increased CamKII activity 4-fold (Fig-
ure 6A). However, this increase in CamKII activity was
inhibited in cells pretreated with 10 nM TNP-470. Atten-
uation of MetAP-2 protein levels via siRNA also inhibited
CamKII activation upon treatment with isoproterenol
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1005Figure 5. MetAP-2 Is Essential in Noncanon-
ical Wnt Signaling but Has a Negligible Effect
on the Canonical Wnt/b-Catenin Pathway
(A) F9 cell differentiation induced by 10 mM
isoproterenol in cells expressing chimeric
b2-AR/Rfz2 and b2-AR/Rfz1 was monitored
by immunofluorescence staining with
TROMA-1 antibody.
(B) MetAP-2 protein levels in F9 cells ex-
pressing b2-AR/Rfz2 or b2-AR/Rfz1 with
MAP2-targeting siRNA.
(C) F9 cells expressing chimeric b2-AR/Rfz1
transfected with the pTOPflash reporter
plasmid and treated with 10 mM isoprotere-
nol for 6 hr. Relative LEF/TCF-luciferase
activities of triplicate samples are presented
as fold induction. Means + SD are shown
(n = 6).(Figure 6A). These data are consistent with the activated
CamKIItr rescue of MetAP-2 downregulation in zebra-
fish (Figure 3F) and confirm the requirement of MetAP-
2 activity in the Wnt/Ca2+ signaling pathway.
Since JNK is reported to be downstream of noncanon-
ical Wnt signaling [32, 33] and has been implicated in
controlling endothelial cell proliferation [34], we next
tested whether JNK activity can be regulated by TNP-
470 by using phospho-63-c-jun antibody. As shown in
Figure 6B, Wnt5a-stimulated JNK activity in Rfz2-ex-
pressing F9 cells was inhibited when these cells were
pretreated with TNP-470 for 16 hr. This result indicates
that MetAP-2 acts upstream of c-Jun activation.
The small GTPase RhoA is another important down-
stream component of the noncanonical Wnt signaling
pathway. In pull-down assays with the Rho binding do-
main (RBD) from the effector protein Rhotekin, Wnt5a-
stimulated RhoA activity was blocked by pretreatment
of mouse pulmonary endothelial (MPE) cells with TNP-
470 for 16 hr (Figure 6C). It is interesting to note that
both c-jun and RhoA are critical factors involved in
angiogenesis [34, 35].
Activation of Noncanonical Wnt Signaling Rescues
TNP-470 Sensitivity in Endothelial Cells
Given our result that MetAP-2 acts downstream of non-
canonical Wnt signaling, we next explored whether
TNP-470-induced cell cycle arrest in endothelial cells
could be rescued by activation of the downstream Wnt
effector Dishevelled. We used DDIX-Dvl2 that contained
an amino-terminal deletion of the DIX domain of Dishev-
elled-2, which preferentially activated noncanonical Wnt
signaling in a Fz-independent manner [8, 36]. Stable
introduction of a DDIX-Dvl2 construct into MPE cellsreduces endothelial cell sensitivity to TNP-470 by
w10-fold (Figure 6D). This was also observed in another
endothelial cell type, HUVE cells stably expressing
DDIX-Dvl2 (data not shown). These pooled retrovirus-in-
fected HUVE cells do not represent an individual clone,
thereby precluding the possibility that the distinct sensi-
tivities are due to clonal differences in responsiveness.
These data indicate that overexpression of activated
Dishevelled-2 partially rescues the loss of noncanonical
Wnt signaling upon TNP-470 treatment. In addition,
these results suggest that inhibition of noncanonical
Wnt signaling by TNP-470 may be partially responsible
for its cytostatic effect. Taken together, our findings
place the need for MetAP-2 activity in noncanonical
Wnt signaling proximal to Frizzled activation of Dishev-
elled and upstream of calcium signaling, RhoA, and
JNK activation [36].
Discussion
The identification of selective small-molecule inhibitors
can greatly aid the investigation of intracellular signaling
pathways. Here, we continue our mode of action studies
of TNP-470 by combining model organism chemical
genetic and traditional genetics approaches to demon-
strate that the target of TNP-470, MetAP-2, is essential
for noncanonical Wnt signaling, which plays a critical
role in development, cell differentiation, and tumorigen-
esis. Given the several shared components between
noncanonical and canonical Wnt/b-catenin signaling
pathways, our finding that TNP-470 selectively inhibits
noncanonical Wnt signaling over canonical Wnt sig-
naling in a MetAP-2-dependent manner will aid the
Chemistry & Biology
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by these important signaling pathways.
Our studies narrow the point at which MetAP-2 func-
tion is required in this signaling cascade. First, we dem-
onstrated that MetAP-2 is downstream of Wnt and Fz,
since noncanonical Wnt signaling initiated by the iso-
proterenol-inducible chimeric Fz2 receptor was in-
hibited by loss of MetAP-2 activity. While downstream
of Fz, our data show that MetAP-2 is upstream of JNK
and CaMKII activation. We then investigated signaling
more proximal to Fz, and we showed that DDIX-Dvl
was able to convey partial resistance to TNP-470-medi-
ated cell cycle arrest, suggesting that MetAP-2 function
is required upstream or at the level of Dishevelled. Our
finding that TNP-470 inhibits noncanonical Wnt signal-
ing between Frizzled receptors and Dishevelled further
highlights the fact that this is a critical step at which
Figure 6. TNP-470 Regulates Noncanonical Wnt Signaling
(A) F9 cells expressing chimeric b2-AR/Rfz2 with or without siRNA
targeting MAP2 were treated with 100 mM isoproterenol for
10 min with or without pretreatment with 10 nM TNP-470 for
24 hr. CamKII activity was determined by the [g-32P]ATP in vitro
kinase assay with biotin-linked peptide substrate. Means + SD
are shown (n = 3).
(B) Wnt5a-stimulated JNK activation in RFz2-F9 cells in the pres-
ence or absence of 10 nM TNP-470 for 4 hr, 8 hr, and 16 hr, as mea-
sured by phospho-63-c-jun.
(C) Wnt5a-stimulated RhoA activity with or without pretreatment
with 10 nM TNP-470 for 16 hr.
(D) Proliferation of hTERT MPE cells expressing an empty vector
(control) or an activator of noncanonical Wnt signaling, DDIX-
Dvl2, as measured by [3H]thymidine incorporation. Means + SD
are shown (n = 6).canonical and noncanonical Wnt pathways diverge
and is consistent with genetic data fromDrosophila [37].
A critical question left open concerns the substrate
for MetAP-2 that is essential for noncanonical signaling.
Previous studies have implicated members of the per-
tussis-sensitive Gi/o family of heterotrimeric G proteins
downstream of Fz receptors [24, 38]. In addition, Fz-
mediated calcium release was shown to be pertussis
sensitive [25]. Interestingly, Go, which is expressed in
endothelial cells [39], is myristoylated and requires the
action of a methionine aminopeptidase to expose the
penultimate glycine residue for myristic acid coupling
to its amino terminus. It is tempting to speculate that
retention of the Go amino-terminal methionine upon
TNP-470-mediated MetAP-2 inhibition could lead to a
dominant-negative Go protein that subsequently blocks
noncanonical Wnt signaling. Experiments to test this
hypothesis are underway.
Another possible connection between MetAP-2 activ-
ity and noncanonical Wnt signaling may be via regula-
tion of protein phosphatase PP2A. Previous studies
have implicated a PP2A inhibitor as a substrate for me-
thionine aminopeptidase activity [40]. Using a nonspe-
cific MetAP inhibitor, bengamide E (3), Towbin and col-
leagues identified nine proteins whose mobility was
altered upon MetAP inhibition. One of these proteins, a
42 kDa PP2A inhibitor, becomes more basic upon ben-
gamide E incubation, consistent with the gain of a
charged methionine amino terminus. Interestingly, wi-
derborst (wdb), a Drosophila mutant with aberrant pla-
nar polarization in wing epithelial cells was identified
as a B0 regulatory subunit of PP2A [41]. This PP2A regu-
latory protein asymmetrically localizes to the distal side
of a planar web of microtubules in the Drosophila wing
epithelium. Genetic studies have shown wdb to be a
conserved component of planar cell polarity in bothDro-
sophila and zebrafish. It is interesting to note that, like
Frizzled and Dishevelled, PP2A is another shared com-
ponent in both canonical and noncanonical Wnt path-
ways. Studies have shown that PP2A is required for
Wnt/b-catenin signaling in the developing embryo [42,
43]. While only speculative at this moment, it is possible
that retention of the amino-terminal methionine of the
PP2A inhibitor upon MetAP-2 inhibition could result in
aberrant PP2A regulation, leading to loss of noncanoni-
cal Wnt signaling without affecting Wnt/b-catenin sig-
naling. Epistasis studies with Drosophila MetAP-2 and
wdb mutants may provide a connection between
MetAP-2 and wdb. It is interesting to note that other
genetic evidence, consistent with our conclusion that
MetAP-2 plays an important role in noncanonical Wnt
signaling, already exists. In support of our zebrafish
and cell culture data, previous studies have shown
that loss of MetAP-2 in Drosophila leads to an embry-
onic lethal phenotype; however, a weaker allele results
in loss of ommatidial dorsal/ventral patterning in the
eye, a characteristic phenotype of noncanonical Wnt
signaling misregulation [44].
While other small-molecule agonists and antagonists
of Wnt signaling have been reported [17, 18], we show
that TNP-470 is the first, to our knowledge, small mole-
cule capable of regulating noncanonical, but not canon-
ical, Wnt signaling. Our finding that this potent antiangio-
genic compound blocks noncanonical Wnt signaling
Fumagillin, TNP-470 Block Noncanonical Wnt Signaling
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esis, which would provide many new potential drug tar-
gets for antiangiogenic therapeutic development.
Significance
The natural product fumagillin and its analog, TNP-
470, possess promising antiangiogenic and antitumor
activities. Despite initial reports that the metallopro-
tease methionine aminopeptidase 2 (MetAP-2) is tar-
geted and inhibited by this potent class of compounds
and that the resulting cell cycle arrest requires p53, lit-
tle was known about the physiological role of MetAP-2.
In efforts to address this issue, we have investigated
the function of MetAP-2 by using a range of animal
and cell culture models, including nucleic acid-based
(MO and siRNA) and chemical approaches. Our results
have shown that MetAP-2 protein and enzymatic activ-
ity are required selectively for noncanonical Wnt (PCP
and Wnt/Ca+2), but not for canonical Wnt/b-catenin
signaling. In addition, epistasis experiments have
placed the requirement for MetAP-2 activity down-
stream of Wnt binding to its receptor, Frizzled, but up-
stream of the noncanonical Wnt effector proteins
CamKII, JNK, and Rho. The identification of fumagillin
and TNP-470 as noncanonical Wnt inhibitors may also
significantly aid in further investigation of this path-
way; whereas, both small-molecule agonists and an-
tagonists have been described for canonical Wnt sig-
naling, the study of noncanonical Wnt signaling has
been hampered by the lack of such tools. Finally, given
that fumagillin and TNP-470 possess potent antiangio-
genic activity as well as inhibit noncanonical Wnt sig-
naling selectively, studies are underway to investigate
the importance of noncanonical Wnt signaling in an-
giogenesis. It is possible that additional compounds
targeting the noncanonical Wnt pathway may also
exhibit antiangiogenic activity.
Experimental Procedures
Cell Culture and Murine Active tPA ELISA Assay
Mouse F9 teratocarcinoma cells were obtained from ATCC; main-
tained in DMEM containing 1.5 g/L sodium bicarbonate, 10% FBS;
and grown on 0.8% gelatin-coated plates. HEK293 cells were ob-
tained from ATCC, and retrovirus packaging gp293 cells were from
Clontech. Bovine aortic endothelial (BAE) cells and murine pulmo-
nary endothelial (MPE) cells were harvested and cultured as previ-
ously described [45]. hTERT MPE cells were cotransfected with
2 mg HA-DDIX-Dvl2 and 0.2 mg pBabe puro vector with Lipofect-
amine 2000 and were selected in 1 mg/ml puromycin. Resistant
clones were picked and analyzed by Western blot. A total of 1 3
104 each of Rfz2-expressing mouse F9 cells and HEK293 cells coex-
pressing HA-Wnt5a (Upstate) and EGFP (Clontech) were cocultured
in 12-well plates precoated with 0.8% gelatin with or without 10 nM
TNP-470. Fresh medium and drug were changed every day for 4
days. Active murine tPA levels in the medium were determined by
using a murine tPA ELISA Kit (Molecular Innovations, Inc.).
Antibodies, Immunoblotting, and Immunofluorescent Staining
Anti-MetAP-2 antibody (Zymed Laboratories), phospho-63-c-jun
antibody (Cell Signaling Technology), anti-HA (Y-11) and anti-JNK1
(C-17) antibody (Santa Cruz Biotechnology), anti-tubulin antibody
(Sigma), and Rhodamine (TRICT)-conjugated anti-rat IgG (Jackson
ImmunoResearch Laboratories) were used according to manufac-
turers’ recommended protocols. For staining of the primitive endo-
derm (PE)-specific marker cytokeratin Endo-A, immunofluorescent
staining was carried out with TROMA-1 antibody (DevelopmentalStudies Hybridoma Bank). Cells were rinsed with PBS, fixed with
3% paraformaldehyde at room temperature for 10 min, and permea-
bilized with 0.2% Triton for 5 min. After blocking in 10% donkey
serum, cells were incubated with partially purified TROMA-1 anti-
body (1:10) in 1% BSA for 1 hr, followed by three washes (10 min
each) with PBS. Samples were then incubated in the secondary an-
tibody Rhodamine (TRICT)-conjugated anti-rat IgG (1:200) in 1%
BSA at room temperature for 30 min, followed by three washes
(10 min each) with PBS. Pictures were taken by a digital camera
(Olympus C-3040ZOOM) linked to a fluorescent microscope (Olym-
pus CK40).
siRNA Targeting Murine MetAP-2
Deoxyoligonucleotides encoding siRNA against murine MetAP-2
were synthesized at the Keck Biotechnology Center (Yale School of
Medicine). Sense oligonucleotide 50-GGGTCATATACAGCACAGT-
30 and the antisense 50-ACTGTGCTGTATATGACCC-30 were cloned
into the BglII/HindIII sites of retrovirus pSUPER vector (OligoEngine).
Retrovirus containing siRNA against murine MetAP-2 was produced
with the Pantropic Retroviral Expression System (Clontech) and were
used to infect F9 cells before selection with 1 mg/ml puromycin.
[3H]Thymidine Uptake Assay
Assays for thymidine uptake were carried out as previously de-
scribed [45]. Each data point is the average of six values.
Luciferase Assay
F9 cells (20,000) expressing the b2-AR/Rfz1 chimera were seeded
into each well of 24-well plates 24 hr before transfection. Cells
were transfected with the pTOPflash plasmid by using Lipofect-
amine 2000 according to the manufacturer’s protocol (Invitrogen,
Carlsbad, CA). After 16 hr, the cells were treated with isoproterenol
(10 mM) for 6 hr, fumagillin (10 nM) for 2 hr, followed by fumagillin plus
isoproterenol for another 6 hr or DMSO for 8 hr. Then, cells were har-
vested and analyzed with the Promega luciferase assay system, and
luciferase activity was determined with the PerkinElmer Wallac 1420
multilabel counter. The fold increase was calculated as follows:
Fold increase=
Luc activity with iso after 6 hours2Luc activity before induction
Luc activity without iso after 6 hours2Luc activity before induction
:
CamKII Assay
CamKII activation in F9 cells was determined by using the Signal-
TECT Calcium/Calmodulin-Dependent Protein Kinase (CaMKII) As-
say System (Promega Corporation). Briefly, 107 F9 cells carrying
the b2-AR/Rfz2 chimera with or without MetAP-2 knockdown by
siRNA were treated with 100 mM isoproterenol for 10 min with or
without pretreatment with 10 nM TNP-470 for 24 hr. Cells were lysed
in 25 mM Tris-HCl (pH7.4), 0.5 mM EDTA, 0.5 mM EGTA, 0.05% Tri-
ton, 10 mM b-mercaptoethanol, 2.5 mM sodium pyrophosphate,
1 mM b-glycerophosphate, 1 mM sodium orthovanadate, 1 mg/ml
leupeptin, and 1 mM phenylmethylsulfonyl fluoride. CamKII activity
was determined by a [g-32P]ATP in vitro kinase assay with biotin-
linked peptide substrate that was performed according to the man-
ufacturer’s protocols. Average values represent experiments done
in triplicate.
RhoA Activity Assay
RhoA activity was determined by a GST-RBD pull-down assay with
the EZ-Detect Rho Activation Kit (Pierce). Briefly, 107 MPE cells were
preincubated with or without 10 nM TNP-470 for 16 hr, stimulated
with Wnt5a conditioned medium for 1 hr, and washed with PBS.
The assay was performed according to the manufacturer’s protocol.
Cloning and Whole-Mount In Situ Hybridization in Zebrafish
To clone zebrafish MetAP-2 homologs, human MetAP-2 was used
as a query in a BLAST search of the zebrafish genomic database
(http://www.ensembl.org/Danio_rerio/). As a result, two zebrafish
MetAP-2 sequences were identified (on chromosome 4, and 25
[NCBI accession code: NM199640]). Gene-specific primers were
designed and used to amplify MetAP-2 products from a 24 hr post
fertilization cDNA library. PCR products were cloned into the TA
Cloning Vector (InVitroGen) and confirmed by sequencing.
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1008For whole-mount in situ hybridization, embryos were fixed in 4%
paraformaldehyde/13 PBS. Digoxygenin-UTP-labeled antisense
RNA probes (Roche) were synthesized by using SP6 RNA polymer-
ase from XhoI-linearized MetAP-2 templates and T7 RNA polymer-
ase from BamHI-linearized Wnt5 templates. After detection, em-
bryos were mounted and photographed.
Morpholinos and Zebrafish Microinjection
Wild-type WIK and TLF zebrafish embryos were obtained by natural
crosses. Embryos were microinjected with a pneumatic injector
(WPI) at the one-cell stage. Morpholinos (Gene-Tools) for zebrafish
MetAP-2 (Chromosome 25) (50-CATGTCTTTACCCATCTTGCACAG
G-30), the 5 bp mismatched (in lowercase letters) control missense
MetAP-2 MO (50-CATGTgTTTgCCgATC TTGgACAcG-30), and Wnt5
(50-GTCCTTGGTTCATTCTCACATCCAT-30) were injected at con-
centrations of 600 mM (MetAP-2 and missense MetAP-2) and
330 mM (Wnt5) in 13 Danieau solution. Synergy experiments were
conducted at 300 mM and 150 mM for MetAP-2 and Wnt5, respec-
tively. The ‘‘single’’ low-dose MO injections for the synergistic exper-
iments were supplemented with control MO to bring up the total
injected MO amount to a level equal to that of the combined Wnt5/
MetAP-2 double MO injection experiments. In vitro-transcribed
CaMKIItr (70–100 ng/ml) was coinjected with MetAP-2 morpholinos.
Injected embryos were reared at 28C and assayed after 24 hr of de-
velopment. Live embryos were mounted in methylcellulose, and im-
ages were captured at 53 magnification with a Zeiss axiocam.
Supplemental Data
Supplemental Data include zebrafish MetAP-2, MyoD, and Wnt5
expression analyses in wild-type and MetAP-2 MO-injected fish
and are available at http://www.chembiol.com/cgi/content/full/
13/9/1001/DC1/.
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